ReWalk Robotics to Discuss Medicare’s Preliminary Payment Determination for ReWalk Personal Exoskeleton
07 11월 2023 - 10:00PM
ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”), a
leading provider of innovative technologies that enable mobility
and wellness in rehabilitation and daily life for individuals with
neurological conditions, today announced that that it has scheduled
a conference call for Wednesday, November 8, 2023 at 8:30 a.m. EST,
to discuss Medicare’s preliminary payment determination for the
ReWalk Personal Exoskeleton.
On Friday, November 3, the Centers for Medicare &
Medicaid Services (“CMS”) released an agenda for the upcoming
Healthcare Common Procedure Coding System (“HCPCS”) meeting
on November 29, 2023, which includes an item to discuss
the Medicare payment determination for the ReWalk Personal
Prosthetic Exoskeleton system and provides a preliminary payment
determination of $94,617.
Larry Jasinski, Chief Executive Officer, Jeannine Lynch, Vice
President of Market Access and Strategy, and Mike Lawless,
Chief Financial Officer, will host a conference call at 8:30
a.m. EST to discuss the potential impact of this announcement.
To access the call, analysts and investors may utilize the
following:
Toll free (U.S.) |
1-833-316-0561 |
International (U.S) |
1-412-317-0690 |
Germany |
0800-6647650 |
Israel |
1-80-9212373 |
Access Code |
Please reference the “ReWalk
Robotics Ltd. Call” |
|
|
The conference call will be webcast live and the webcast can be
accessed through a link on the Company’s website at
rewalk.com in the "Investors" section, or through the
following link: https://edge.media-server.com/mmc/p/664yxytg/.
An archived webcast will also be available on the company's
website.
About ReWalk Robotics Ltd.ReWalk Robotics
Ltd. is a medical device company that designs, develops, and
commercializes innovative technologies that enable mobility and
wellness in rehabilitation and daily life for individuals with
neurological conditions. ReWalk’s mission is to fundamentally
change the quality of life for these individuals through the
creation and development of market leading technologies. Through
its recent acquisition of AlterG, Inc., ReWalk has added
anti-gravity systems to its growing portfolio of products. Founded
in 2001, ReWalk has operations in the United
States, Israel, and Germany. For more information on the
ReWalk systems, please visit rewalk.com. For more information
on the AlterG systems, please visit alterg.com.
ReWalk® and ReStore® are registered trademarks
of ReWalk Robotics Ltd. in the United
States and other jurisdictions. AlterG® is a registered
trademark of AlterG, Inc. in the United
States and other jurisdictions.
ReWalk Media Relations:LifeSci CommunicationsE:
media@rewalk.comReWalk Investor Contact:Mike LawlessChief Financial
OfficerReWalk Robotics LtdE: investorrelations@rewalk.com
ReWalk Robotics (NASDAQ:RWLK)
과거 데이터 주식 차트
부터 12월(12) 2024 으로 1월(1) 2025
ReWalk Robotics (NASDAQ:RWLK)
과거 데이터 주식 차트
부터 1월(1) 2024 으로 1월(1) 2025